InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,973.10
(
0.74%
)
US TECH 100
20,558.40
(
1.66%
)
Dow Jones
43,729.34
(
0.00%
)
Brent Oil
75.44
(
0.49%
)
Bitcoin
76,219.61
(
0.76%
)
Post# of 253543
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120679
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 1583

Thursday, 03/25/2004 4:37:54 PM

Thursday, March 25, 2004 4:37:54 PM

Post# of 253543
The Squalamine IND in AMD has already been filed:

From page 4 of GENR’s just-filed 10K report:

http://www.sec.gov/Archives/edgar/data/880431/000119312504049198/d10k.htm

>>
In March 2004, we submitted an Investigational New Drug Application (IND) to the Food and Drug Administration of the United States (FDA) to conduct clinical trials of squalamine in ophthalmic indications including the treatment of wet AMD.
<<

Note the use of the word trials (plural)!


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up